Solutions / Due Diligence & Research / Commercial Due Diligence

Commercial Due Diligence

Most deals are priced on a management growth case. Commercial diligence exists to find out whether that case survives contact with the target's actual customers and market.

Customers actually contactedCurrent, former and prospective customers interviewed on satisfaction, spend intent and switching risk.

The load-bearing assumption foundThe one or two assumptions carrying the valuation are identified and tested separately.

Findings, not comfortIf the growth case does not hold, that is what the report says.

CommercialFinancialOperational RegulatoryTechnology deal-relevantdeal-relevant materiality threshold
Findings above the materiality thresholdLogged, evidenced, below threshold

In simple terms

You tell us the deal and the thesis. We test the target's market, customers and growth case independently, and tell you which parts hold and which do not.

What Commercial Due Diligence is. Commercial due diligence independently tests the target's market position, customer relationships, competitive exposure and growth assumptions, and states plainly which parts of the investment case hold and which do not.

What makes this different. A review that always supports the transaction is comfort, not diligence. Ours reports what it finds, including the findings that change the price or stop the deal.

What the service covers

These are the areas we work across, such as the ones below. We combine them in the proportion your question needs, and we tell you which ones your question does not need.

Market assessment

Independent sizing, growth and structure analysis, tested against the target's own market claims.

Customer testing

Structured interviews with current, former and prospective customers on satisfaction, spend intent and switching risk.

Competitive position

Where the target genuinely holds advantage, how durable it is, and what erodes it inside the hold period.

Growth case testing

Each assumption in the plan tested separately, with the ones that carry the valuation identified explicitly.

Questions this answers

If something like this is on your agenda, the engagement is already half scoped.

  • Is the market growing at the rate management claims?
  • How sticky are the top customers, in their own words?
  • Is the pipeline real, or the same opportunities recycled across three quarters?
  • What competitive threat is credible within the hold period?
  • Which assumption in the model does the whole valuation rest on?

How you can use this

A few of the situations where this service does real work.

Screening before full scope

You need to know quickly whether this asset is worth full diligence.

Deal-stoppers surfaced before the budget is committed

Testing a growth plan

Management projects strong growth and the basis is unclear.

Each assumption tested against independent evidence

Checking customer stickiness

Revenue is concentrated and retention is assumed.

Switching risk established from the customers themselves

Competitive threat in the hold period

A rival could erode the position before you exit.

Durability assessed against your actual hold period

What changes for your business

The practical difference between running on this and running on what you have now, such as the following.

You price the risk instead of discovering it

Issues found in your own diligence are negotiable. Issues found in the other side's are deductions.

You spend diligence budget in the right order

A fast screen surfaces deal-stoppers before you commit to full scope on an asset that will not clear.

Committee papers stand up

Findings are evidenced, severity-rated and structured the way an investment committee expects to receive them.

You get the uncomfortable findings too

A review that only supports the deal is comfort, not diligence. Ours reports what it finds.

Valuation rests on tested assumptions

The parts of the model carrying the valuation are identified and tested separately, rather than accepted as a set.

You can act on it after close

Findings come with commercial consequence and owner, so the first hundred days start from something concrete.

Who this is for

Roles that commission this work most often include those below. Each asks a different question and gets a different cut of the same evidence.

Investors and deal teams

Does the investment case hold under independent testing?

Findings with severity, evidence and commercial consequence, in a format an investment committee accepts.

Corporate development

Are we buying what we think we are buying?

Independent assessment of market position, customers and growth assumptions, including the uncomfortable parts.

Finance and CFO teams

Are these numbers defensible?

Reconstructed and normalised financials with the estimation method stated wherever disclosure runs out.

Risk and compliance leadership

What are we inheriting that we have not priced?

Regulatory, environmental and governance exposure with cost and timing attached.

Founders and vendors preparing to sell

What will a buyer find that we have not addressed?

The issues a buyer's adviser will raise, ranked by likely price impact and whether they can still be fixed.

Typical clients

Private equity, venture and growth investorsCorporates making acquisitionsFounders and vendors preparing for an exitLenders and credit committeesAdvisory and transaction services firms

How we work

The third step is the one that makes the output usable, and it is the one most work of this kind skips.

Step 1

Understand the decision

We start from the decision the work supports: proceed, reprice, or walk. That decides what has to be proven and to what standard.

Step 2

Gather and test independently

Market, customer and financial evidence gathered directly, then tested against what management has represented.

Step 3

Read it for your position

What matters depends on your hold period, your thesis and your risk appetite. The same finding is fatal for one buyer and immaterial to another.

Step 4

Report to committee standard

Findings with severity, evidence and commercial consequence, structured the way an investment committee expects to receive them.

One finding established once Upstream supplierProducer or provider Channel or partnerInvestor Secure capability earlyBring the change forward Prepare for the shiftReprice the exposure four different recommended actions
Step three in practice. Your position decides what a finding means.

What you receive

Diligence report structured to investment committee standard

Findings register with severityevidence and commercial consequence

Financial or commercial model with scenarios

Management presentation and a live question session

Access to Phi, our AI research platformincluded

Every engagement comes with access to Phi. Ask questions of your own findings in plain language, pull the evidence behind any number, and keep querying long after the work is delivered. Your team gets the working intelligence, not just the document.

Open Phi
Request a sample Real work with the client's identity removed.

Ways to start

Tell us the decision and the date it has to be made by. We will recommend the smallest engagement that gets you there.

1-2 weeks

Red-flag review

A fast screen surfacing the issues that would stop a deal, before you spend more.

3-6 weeks

Full diligence

Complete commercial, financial or operational review to committee standard.

Ongoing

Portfolio monitoring

Continuous watch on holdings, with alerts on material change.

Common questions

How fast can you turn this around?

A red-flag review in one to two weeks; full diligence in three to six, depending on customer interview access.

What if you disagree with the investment thesis?

We say so, with the evidence. A diligence provider whose findings always support the deal is providing comfort, not diligence.

Who owns the work?

You do. It is exclusive to you, it is not resold, and working files are handed over unlocked.

Will you sign an NDA?

Yes, before the first conversation if you prefer.

Tell us the decision you are facing

Send us the question, the context and your timeline. You get back a recommended first step, what evidence it needs, and what it costs. Not a capability deck.